 All subjects will receive dietary instructions according to National Cholesterol Education Program Adult Treatment Panel III NCEP-ATP III by a clinical nutritionist. If LDL-C is still above recommended levels after 3 months of appropriate lifestyle changes, patients will be randomly allocated to open-label simvastatin 40 mg n50 or simvastatinezetimibe 1010 mg n50 daily. 